Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401603
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-02
Brief Title:
A Phase I Study of Decitabine Lisaftoclax and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-02
First Submit QC Date:
May 2 2024
Study First Post Date:
2024-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL